Percutaneous Coronary Intervention in Patients With Insulin-Treated and Non–Insulin-Treated Diabetes Mellitus
Open Access
- 1 June 2016
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 1 (3) , 266-273
Abstract
Patients with diabetes mellitus (DM) often have rapidly progressive, extensive coronary artery disease leading to long and diffuse lesions in small-caliber coronary arteries, which renders revascularization challenging.1 As such, when compared with patients without DM, patients with DM have had worse outcomes following percutaneous coronary intervention (PCI) in the balloon angioplasty era, bare-metal stent (BMS) era, and even in the drug-eluting stent era, with higher rates of in-stent restenosis, stent thrombosis, death, and myocardial infarction (MI).1-4 Among patients with DM undergoing revascularization, those treated with insulin have been shown to have worse outcomes compared with those not treated with insulin.5-8 However, this finding is controversial, as other studies have shown that the increased possibility of adverse cardiovascular outcomes in patients with insulin-treated DM (ITDM) disappears after risk adjustment.9Keywords
This publication has 13 references indexed in Scilit:
- Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in DiabetesNew England Journal of Medicine, 2015
- Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin-treated diabetes mellitusEuroIntervention, 2014
- Differential Clinical Responses to Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients With and Without Diabetes MellitusCirculation, 2011
- Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methodsEuropean Heart Journal, 2006
- Drug-eluting stents: meta-analysis in diabetic patientsEuropean Heart Journal, 2004
- Diabetes Is Still a Risk Factor for Restenosis After Drug-Eluting Stent in Coronary ArteriesDiabetes Care, 2004
- The Relationship of Fasting Serum Radioimmune Insulin Levels to Incident Coronary Heart Disease in an Insulin-Treated Diabetic CohortThe Journal of Clinical Endocrinology & Metabolism, 2004
- Comparison of survival after successful percutaneous coronary intervention of patients with diabetes mellitus receiving insulin versus those receiving only diet and/or oral hypoglycemic agentsThe American Journal of Cardiology, 2004
- Using Propensity Scores to Help Design Observational Studies: Application to the Tobacco LitigationHealth Services and Outcomes Research Methodology, 2001
- The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantationJACC, 1998